United Therapeutics Corp (UTHR)
234.36
+0.30
(+0.13%)
USD |
NASDAQ |
Apr 23, 16:00
234.42
+0.06
(+0.03%)
Pre-Market: 20:00
United Therapeutics Gross Profit (TTM): 2.07B for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 2.07B |
September 30, 2023 | 1.959B |
June 30, 2023 | 1.898B |
March 31, 2023 | 1.803B |
December 31, 2022 | 1.785B |
September 30, 2022 | 1.733B |
June 30, 2022 | 1.671B |
March 31, 2022 | 1.643B |
December 31, 2021 | 1.563B |
September 30, 2021 | 1.532B |
June 30, 2021 | 1.472B |
March 31, 2021 | 1.398B |
December 31, 2020 | 1.375B |
September 30, 2020 | 1.307B |
June 30, 2020 | 1.320B |
March 31, 2020 | 1.331B |
December 31, 2019 | 1.331B |
September 30, 2019 | 1.398B |
June 30, 2019 | 1.391B |
March 31, 2019 | 1.427B |
December 31, 2018 | 1.429B |
September 30, 2018 | 1.491B |
June 30, 2018 | 1.556B |
March 31, 2018 | 1.599B |
December 31, 2017 | 1.620B |
Date | Value |
---|---|
September 30, 2017 | 1.588B |
June 30, 2017 | 1.547B |
March 31, 2017 | 1.514B |
December 31, 2016 | 1.526B |
September 30, 2016 | 1.525B |
June 30, 2016 | 1.520B |
March 31, 2016 | 1.458B |
December 31, 2015 | 1.397B |
September 30, 2015 | 1.348B |
June 30, 2015 | 1.258B |
March 31, 2015 | 1.210B |
December 31, 2014 | 1.163B |
September 30, 2014 | 1.082B |
June 30, 2014 | 1.065B |
March 31, 2014 | 1.029B |
December 31, 2013 | 985.86M |
September 30, 2013 | 941.77M |
June 30, 2013 | 884.76M |
March 31, 2013 | 832.42M |
December 31, 2012 | 796.78M |
September 30, 2012 | 760.48M |
June 30, 2012 | 725.04M |
March 31, 2012 | 691.69M |
December 31, 2011 | 654.28M |
September 30, 2011 | 629.58M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
1.307B
Minimum
Sep 2020
2.07B
Maximum
Dec 2023
1.578B
Average
1.532B
Median
Sep 2021
Gross Profit (TTM) Benchmarks
Liquidia Corp | 14.60M |
Esperion Therapeutics Inc | 73.07M |
Vertex Pharmaceuticals Inc | 8.607B |
Heron Therapeutics Inc | 61.94M |
Aldeyra Therapeutics Inc | -- |